The clinical features of the 31 BRCA1-mutated patients were compared with those of the 25 BRCA2-mutated patients with no statistically significant differences, except for the grading of BC with a higher number of poorly differentiated tumors in BRCA1-mutated patients (Supplementary Tables 4 and 5). This evidence concerns the gene BRCA2 and breast cancer.